These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune checkpoint inhibitors for urothelial carcinoma. Kim HS; Seo HK Investig Clin Urol; 2018 Sep; 59(5):285-296. PubMed ID: 30182073 [TBL] [Abstract][Full Text] [Related]
3. Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial). Martinez Chanza N; Soukane L; Barthelemy P; Carnot A; Gil T; Casert V; Vanhaudenarde V; Sautois B; Staudacher L; Van den Brande J; Culine S; Seront E; Gizzi M; Albisinni S; Tricard T; Fantoni JC; Paesmans M; Caparica R; Roumeguere T; Awada A BMC Cancer; 2021 Dec; 21(1):1292. PubMed ID: 34856936 [TBL] [Abstract][Full Text] [Related]
4. Current and future perspectives in advanced bladder cancer: is there a new standard? von der Maase H Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study. Halim A; Abotouk N Asia Pac J Clin Oncol; 2013 Mar; 9(1):60-5. PubMed ID: 22897883 [TBL] [Abstract][Full Text] [Related]
10. Novel gemcitabine-containing triplets in the management of urothelial cancer. Hussain M; Vaishampayan U; Smith DC Semin Oncol; 2002 Feb; 29(1 Suppl 3):20-4. PubMed ID: 11894004 [TBL] [Abstract][Full Text] [Related]
11. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. Shelley M; Cleves A; Wilt TJ; Mason M Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413 [TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and cisplatin for advanced, metastatic bladder cancer. Cohen MH; Rothmann M J Clin Oncol; 2001 Feb; 19(4):1229-31. PubMed ID: 11181690 [No Abstract] [Full Text] [Related]
13. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer. Galsky MD; Pal SK; Chowdhury S; Harshman LC; Crabb SJ; Wong YN; Yu EY; Powles T; Moshier EL; Ladoire S; Hussain SA; Agarwal N; Vaishampayan UN; Recine F; Berthold D; Necchi A; Theodore C; Milowsky MI; Bellmunt J; Rosenberg JE; Cancer; 2015 Aug; 121(15):2586-93. PubMed ID: 25872978 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions. Tripathi A; Plimack ER Curr Urol Rep; 2018 Nov; 19(12):109. PubMed ID: 30406502 [TBL] [Abstract][Full Text] [Related]
15. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature. Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730 [TBL] [Abstract][Full Text] [Related]
16. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma]. Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of immunotherapy in urothelial carcinoma-Advanced disease. Zibelman M; Ramamurthy C; Plimack ER Urol Oncol; 2016 Dec; 34(12):538-547. PubMed ID: 27888981 [TBL] [Abstract][Full Text] [Related]
18. Systemic chemotherapy of transitional cell carcinoma of the urothelium. Brinkley WM; Torti FM Semin Surg Oncol; 1997; 13(5):365-75. PubMed ID: 9259093 [TBL] [Abstract][Full Text] [Related]
19. Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma. Small EJ J Clin Oncol; 2023 Aug; 41(23):3879-3880. PubMed ID: 37549481 [No Abstract] [Full Text] [Related]
20. Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma. Koshkin VS; Grivas P Curr Oncol Rep; 2018 Apr; 20(6):48. PubMed ID: 29644490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]